DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
复制标题
DOI:
10.1038/35050500
复制
发表时间:
2001-01-01
影响因子:
21.3
通讯作者:
Kimchi, A
中科院分区:
文献类型:
--
作者:
Raveh, T;Droguett, G;Kimchi, A
DAP kinase is a pro-apoptotic calcium-regulated serine/threonine kinase, whose expression is frequently lost in human tumours, Here we show that DAP kinase counteracts oncogene-induced transformation by activating a p19(ARF)/p53-dependent apoptotic checkpoint. Ectopic expression of DAP kinase suppressed oncogenic transformation of primary embryonic fibroblasts by activating p53 in a p19(ARF)-dependent manner. Consequently, the fibroblasts underwent apoptosis, characterized by caspase activation and DNA fragmentation. In response to c-Myc or E2F-1, the endogenous DAP kinase protein was upregulated. Furthermore, functional or genetic inactivation of the endogenous DAP kinase reduced the extent of induction of p19(ARF)/p53 and weakened the subsequent apoptotic responses to c-Myc or E2F-1. These results establish a role for DAP kinase in an early apoptotic checkpoint designed to eliminate pre-malignant cells during cancer development.